Key result
In rats, PVN terminal inhibition in the nTS strongly attenuated the phrenic amplitude response to hypoxia and augmented tachycardic and sympathetic responses.
Why the study?
The role of paraventricular nucleus (PVN) efferent projections to specific cardiorespiratory nuclei in chemoreflex neurocircuitry was unclear.
The PVN and its projections to the nTS play a critical role in shaping sympathetic and respiratory responses to acute hypoxia in a rat model.
Rat findings on brainstem hypoxic modulation should not change practice; leaves open translation to human cardiorespiratory control.
Chemoreflex neurocircuitry includes the paraventricular nucleus (PVN), but the role of PVN efferent projections to specific cardiorespiratory nuclei is unclear. We hypothesized that the PVN contributes to cardiorespiratory responses to hypoxia via projections to the nucleus tractus solitarii (nTS). Rats received bilateral PVN microinjections of adeno-associated virus expressing inhibitory designer receptor exclusively activated by designer drug (GiDREADD) or green fluorescent protein (GFP) control. Efficacy of GiDREADD inhibition by the designer receptor exclusively activated by designer drug (DREADD) agonist Compound 21 (C21) was verified in PVN slices; C21 reduced evoked action potential discharge by reducing excitability to injected current in GiDREADD-expressing PVN neurons. We evaluated hypoxic ventilatory responses (plethysmography) and PVN and nTS neuronal activation (cFos immunoreactivity) to 2 h hypoxia (10% O2) in conscious GFP and GiDREADD rats after intraperitoneal C21 injection. Generalized PVN inhibition via systemic C21 blunted hypoxic ventilatory responses and reduced PVN and also nTS neuronal activation during hypoxia. To determine if the PVN-nTS pathway contributes to these effects, we evaluated cardiorespiratory responses to hypoxia during selective PVN terminal inhibition in the nTS. Anesthetized GFP and GiDREADD rats exposed to brief hypoxia (10% O2, 45 s) exhibited depressor and tachycardic responses and increased sympathetic and phrenic nerve activity. C21 was then microinjected into the nTS, followed after 60 min by another hypoxic episode. In GiDREADD but not GFP rats, PVN terminal inhibition by nTS C21 strongly attenuated the phrenic amplitude response to hypoxia. Interestingly, C21 augmented tachycardic and sympathetic responses without altering the coupling of splanchnic sympathetic nerve activity to phrenic nerve activity during hypoxia. Data demonstrate that the PVN, including projections to the nTS, is critical in shaping sympathetic and respiratory responses to hypoxia.
No takes yet. Share an insight, caveat, or question.
Ruyle et al. (2019) studied Hypoxia response. PVN terminal inhibition via GiDREADD and C21 vs. GFP control was evaluated on Hypoxic ventilatory responses, neuronal activation, and phrenic amplitude response. In rats, PVN terminal inhibition in the nTS strongly attenuated the phrenic amplitude response to hypoxia and augmented tachycardic and sympathetic responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: